80_FR_19155 80 FR 19087 - Food and Drug Administration Science Forum 2015; Public Workshop

80 FR 19087 - Food and Drug Administration Science Forum 2015; Public Workshop

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 80, Issue 68 (April 9, 2015)

Page Range19087-19088
FR Document2015-08156

Federal Register, Volume 80 Issue 68 (Thursday, April 9, 2015) 
[Federal Register Volume 80, Number 68 (Thursday, April 9, 2015)]
[Notices]
[Pages 19087-19088]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-08156]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-0001]


Food and Drug Administration Science Forum 2015; Public Workshop

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a public 
workshop entitled ``FDA Science Forum 2015.'' The purpose of the public 
workshop is to highlight science conducted at the FDA by showcasing how 
scientific research informs regulatory decision making and to provide a 
forum for developing collaborations within FDA and with external 
organizations. The focus of the forum will be the eight FDA Regulatory 
Science priority areas

[[Page 19088]]

(http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm267719.htm).
    Date and Time: The public workshop will be held on May 27, 2015, 
from 8:30 a.m. to 3:45 p.m. and May 28, 2015, from 8:30 a.m. to 4 p.m.
    Location: The public workshop will be held at FDA White Oak Campus, 
10903 New Hampshire Ave., Building 31 Conference Center, the Great Room 
(Rm. 1503), Silver Spring, MD 20993-0002. Entrance for the public 
workshop participants (non-FDA employees) is through Building 1 where 
routine security check procedures will be performed. For parking and 
security information, please refer to http://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm.
    Contact Person: Leslie Wheelock, Office of Scientific Professional 
Development, Office of the Chief Scientist, Office of the Commissioner, 
Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, Rm. 
4345, Silver Spring, MD, 301-796-4580, FAX: 301-847-8106, email: 
[email protected].
    Registration: Submit your online registration information 
(including name, title, firm name, address, telephone and email) by May 
15, 2015 at: http://www.fda.gov/scienceresearch/aboutscienceresearchatfda/ucm429403.htm.
    There is no registration fee for the public workshop. Early 
registration is recommended because seating is limited. There will be 
no onsite registration.
    If you need special accommodations due to a disability, please 
contact Leslie Wheelock (see Contact Person) at least 7 days in 
advance.
    Webcast: Please be advised that as soon as possible after the 
Forum, a webcast and report of the public workshop will be accessible 
at: http://www.fda.gov/scienceresearch/aboutscienceresearchatfda/ucm429403.htm.

SUPPLEMENTARY INFORMATION: Each session of the FDA Science Forum will 
have an expert in the area and presentations by FDA staff.

    Dated: April 3, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-08156 Filed 4-8-15; 8:45 am]
 BILLING CODE 4164-01-P

Federal Register / Vol. 80, No. 68 / Thursday, April 9, 2015 / Notices 19087 of about 60 hours per year (5,400 hours Postal mail addressed to the DEPARTMENT OF HEALTH AND total); and 1,230 importers of furs and Commission is subject to delay due to HUMAN SERVICES fur products incur an average heightened security screening. As a recordkeeping burden of 30 hours per result, we encourage you to submit your Centers for Disease Control and year (36,900 hours total)] comment online, or to send it to the Prevention Disclosure: 185,101 hours [(107,585 Commission by courier or overnight [30Day–15–15IG] hours for labeling + 28,316 hours for service. To make sure that the invoices + 49,200 hours for Commission considers your online Agency Forms Undergoing Paperwork advertising).] comment, you must file it at https:// Reduction Act Review; Withdrawal Estimated annual cost burden: ftcpublic.commentworks.com/ftc/ $4,658,000, rounded to the nearest AGENCY: Centers for Disease Control and furrulespra2, by following the Prevention (CDC), Department of Health thousand (solely relating to labor costs). instructions on the web-based form. If and Human Services (HHS). Request for Comments this Notice appears at http:// ACTION: Notice withdrawal. You can file a comment online or on www.regulations.gov, you also may file paper. For the Commission to consider a comment through that Web site. SUMMARY: Due to an information your comment, we must receive it on or collection request oversight, the Centers If you file your comment on paper, before May 11, 2015. Write ‘‘Fur Rules: for Disease Control and Prevention write ‘‘Fur Rules: FTC File No. FTC File No. P074201’’ on your (CDC) requests immediate publication P074201’’ on your comment and on the comment. Your comment—including withdrawal of the 30-Day Federal your name and your state—will be envelope, and mail or deliver it to the following address: Federal Trade Register Notice (FRN) entitled ‘‘Agency placed on the public record of this Forms Undergoing Paperwork proceeding, including, to the extent Commission, Office of the Secretary, 600 Pennsylvania Avenue NW., Suite Reduction Act Review’’ concerning the practicable, on the public Commission Public Health Associate Program Web site, at http://www.ftc.gov/os/ CC–5610 (Annex J), Washington, DC 20580, or deliver your comment to the (PHAP) Alumni Assessment. publiccomments.shtm. As a matter of DATES: The 30-day FRN published on discretion, the Commission tries to following address: Federal Trade Commission, Office of the Secretary, March 25, 2015 at 80 FR 15791 is remove individuals’ home contact withdrawn as of April 9, 2015. information from comments before Constitution Center, 400 7th Street SW., 5th Floor, Suite 5610 (Annex J), FOR FURTHER INFORMATION CONTACT: For placing them on the Commission Web Washington, DC 20024. If possible, further information call (404) 639–7570 site. submit your paper comment to the or mail comments to CDC, Leroy A. Because your comment will be made Commission by courier or overnight Richardson, 1600 Clifton Road, MS D– public, you are solely responsible for service. 74, Atlanta, GA 30333 or send an email making sure that your comment does to omb@cdc.gov. not include any sensitive personal The FTC Act and other laws that the information, such as anyone’s Social Commission administers permit the Leroy A. Richardson, Security number, date of birth, driver’s collection of public comments to Chief, Information Collection Review Office, license number or other state consider and use in this proceeding as Office of Scientific Integrity, Office of the identification number or foreign country appropriate. The Commission will Associate Director for Science, Office of the equivalent, passport number, financial Director, Centers for Disease Control and consider all timely and responsive account number, or credit or debit card Prevention. public comments that it receives on or number. You are also solely responsible [FR Doc. 2015–08139 Filed 4–8–15; 8:45 am] before May 11, 2015. You can find more for making sure that your comment does information, including routine uses BILLING CODE 4163–18–P not include any sensitive health permitted by the Privacy Act, in the information, like medical records or Commission’s privacy policy, at http:// other individually identifiable health DEPARTMENT OF HEALTH AND www.ftc.gov/ftc/privacy.shtm. HUMAN SERVICES information. In addition, do not include any ‘‘[t]rade secret or any commercial or Comments on the information collection requirements subject to Food and Drug Administration financial information which is . . . privileged or confidential,’’ as discussed review under the PRA should also be [Docket No. FDA–2015–N–0001] in Section 6(f) of the FTC Act, 15 U.S.C. submitted to OMB. If sent by U.S. mail, 46(f), and FTC Rule 4.10(a)(2), 16 CFR address comments to: Office of Food and Drug Administration Science 4.10(a)(2). In particular, do not include Information and Regulatory Affairs, Forum 2015; Public Workshop competitively sensitive information Office of Management and Budget, AGENCY: Food and Drug Administration, such as costs, sales statistics, Attention: Desk Officer for the Federal HHS. inventories, formulas, patterns, devices, Trade Commission, New Executive Office Building, Docket Library, Room ACTION: Notice of public workshop. manufacturing processes, or customer names. 10102, 725 17th Street NW., The Food and Drug Administration If you want the Commission to give Washington, DC 20503. Comments sent (FDA) is announcing a public workshop your comment confidential treatment, to OMB by U.S. postal mail, however, entitled ‘‘FDA Science Forum 2015.’’ you must file it in paper form, with a are subject to delays due to heightened The purpose of the public workshop is request for confidential treatment, and security precautions. Thus, comments to highlight science conducted at the Rmajette on DSK2VPTVN1PROD with NOTICES you are required to follow the procedure instead should be sent by facsimile to FDA by showcasing how scientific explained in FTC Rule 4.9(c), 16 CFR (202) 395–5167. research informs regulatory decision 4.9(c). Your comment will be kept making and to provide a forum for David C. Shonka, confidential only if the FTC General developing collaborations within FDA Counsel grants your request in Principal Deputy General Counsel. and with external organizations. The accordance with the law and the public [FR Doc. 2015–08151 Filed 4–8–15; 8:45 am] focus of the forum will be the eight FDA interest. BILLING CODE 6750–01–P Regulatory Science priority areas VerDate Sep<11>2014 15:13 Apr 08, 2015 Jkt 235001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\09APN1.SGM 09APN1

19088 Federal Register / Vol. 80, No. 68 / Thursday, April 9, 2015 / Notices (http://www.fda.gov/ScienceResearch/ DEPARTMENT OF HEALTH AND Contact Person: Caron A. Lyman, Ph.D., SpecialTopics/RegulatoryScience/ HUMAN SERVICES Chief, Scientific Review Officer, Research ucm267719.htm). Programs Review Branch, Division of National Institutes of Health Extramural Activities, National Cancer Date and Time: The public workshop Institute, NIH, 9609 Medical Center Drive, will be held on May 27, 2015, from 8:30 National Cancer Institute; Notice of Room 7W126, Bethesda, MD 20892–9750, a.m. to 3:45 p.m. and May 28, 2015, Closed Meetings 240–276–6348, lymanc@mail.nih.gov. from 8:30 a.m. to 4 p.m. Name of Committee: National Cancer Pursuant to section 10(d) of the Institute Special Emphasis Panel; NCI SPORE Location: The public workshop will Federal Advisory Committee Act, as Review. be held at FDA White Oak Campus, amended (5 U.S.C. App.), notice is Date: June 8–9, 2015. 10903 New Hampshire Ave., Building hereby given of the following meetings. Time: 8:00 a.m. to 5:00 p.m. 31 Conference Center, the Great Room The meetings will be closed to the Agenda: To review and evaluate grant (Rm. 1503), Silver Spring, MD 20993– public in accordance with the applications. 0002. Entrance for the public workshop Place: Bethesda North Marriott Hotel & provisions set forth in sections 552b(c) participants (non-FDA employees) is Conference Center, 5701 Marinelli Road, (4) and 552b(c) (6), title 5 U.S.C., as Bethesda, MD 20852. through Building 1 where routine amended. The grant applications/ Contact Person: Caterina Bianco, MD, security check procedures will be contract proposals and the discussions Ph.D., Scientific Review Officer, Research performed. For parking and security could disclose confidential trade secrets Program Review Branch, Division Of information, please refer to http:// or commercial property such as Extramural Activities, National Cancer www.fda.gov/AboutFDA/ patentable material, and personal Institute, NIH, 9609 Medical Center Drive, WorkingatFDA/BuildingsandFacilities/ information concerning individuals Room 7W116, Bethesda, MD 20892–9750, WhiteOakCampusInformation/ associated with the grant applications, 240–276–6459, biancoc@mail.nih.gov. ucm241740.htm. the disclosure of which would Information is also available on the constitute a clearly unwarranted Institute’s/Center’s home page: http:// Contact Person: Leslie Wheelock, deainfo.nci.nih.gov/advisory/sep/sep.htm, Office of Scientific Professional invasion of personal privacy. where an agenda and any additional Development, Office of the Chief Name of Committee: National Cancer information for the meeting will be posted Scientist, Office of the Commissioner, Institute Special Emphasis Panel; when available. Outstanding Investigator Award 1. (Catalogue of Federal Domestic Assistance Food and Drug Administration, 10903 Date: April 29, 2015. Program Nos. 93.392, Cancer Construction; New Hampshire Ave., Bldg. 1, Rm. Time: 1:00 p.m. to 3:00 p.m. 4345, Silver Spring, MD, 301–796–4580, 93.393, Cancer Cause and Prevention Agenda: To review and evaluate grant Research; 93.394, Cancer Detection and FAX: 301–847–8106, email: applications. Diagnosis Research; 93.395, Cancer FDASciProDev@fda.hhs.gov. Place: National Cancer Institute, Shady Treatment Research; 93.396, Cancer Biology Grove, 9609 Medical Center Drive, Room Research; 93.397, Cancer Centers Support; Registration: Submit your online 6W030, Rockville, MD 20850, (Telephone registration information (including 93.398, Cancer Research Manpower; 93.399, Conference Call). Cancer Control, National Institutes of Health, name, title, firm name, address, Contact Person: Michael B. Small, Ph.D., HHS) telephone and email) by May 15, 2015 Chief, Program and Review Extramural Staff at: http://www.fda.gov/scienceresearch/ Training Office, Division of Extramural Dated: April 3, 2015. aboutscienceresearchatfda/ Activities, National Cancer Institute, 9609 Melanie J. Gray, ucm429403.htm. Medical Center Drive, Room 7W522, Bethesda, MD 20892, 240–276–6438, Program Analyst, Office of Federal Advisory There is no registration fee for the smallm@mail.nih.gov. Committee Policy. public workshop. Early registration is Name of Committee: National Cancer [FR Doc. 2015–08131 Filed 4–8–15; 8:45 am] recommended because seating is Institute Special Emphasis Panel; Targeted BILLING CODE 4140–01–P limited. There will be no onsite Radionuclide Therapy. registration. Date: May 4, 2015. Time: 10:00 a.m. to 6:30 p.m. DEPARTMENT OF HEALTH AND If you need special accommodations Agenda: To review and evaluate contract HUMAN SERVICES due to a disability, please contact Leslie proposals. Wheelock (see Contact Person) at least Place: National Cancer Institute, Shady National Institutes of Health 7 days in advance. Grove, 9609 Medical Center Drive, Room Webcast: Please be advised that as 7W030, Rockville, MD 20850, (Telephone Center for Scientific Review; Notice of Conference Call). Closed Meetings soon as possible after the Forum, a Contact Person: Thomas M. Vollberg, webcast and report of the public Ph.D., Scientific Review Officer, Research workshop will be accessible at: http:// Pursuant to section 10(d) of the Technology and Contract Review Branch, www.fda.gov/scienceresearch/ Federal Advisory Committee Act, as Division of Extramural Activities, National aboutscienceresearchatfda/ Cancer Institute, NIH, 9609 Medical Center amended (5 U.S.C. App.), notice is Drive, Room 7W102, Rockville, MD 20850, hereby given of the following meetings. ucm429403.htm. 240–276–6341, vollbert@mail.nih.gov. The meetings will be closed to the SUPPLEMENTARY INFORMATION: Each Name of Committee: National Cancer public in accordance with the session of the FDA Science Forum will Institute Special Emphasis Panel; NCI R01 provisions set forth in sections have an expert in the area and Review. 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Rmajette on DSK2VPTVN1PROD with NOTICES presentations by FDA staff. Date: May 21, 2015. as amended. The grant applications and Time: 1:00 a.m. to 3:00 p.m. the discussions could disclose Dated: April 3, 2015. Agenda: To review and evaluate grant applications. confidential trade secrets or commercial Leslie Kux, Place: National Cancer Institute, Shady property such as patentable material, Associate Commissioner for Policy. and personal information concerning Grove, 9609 Medical Center Drive, Room [FR Doc. 2015–08156 Filed 4–8–15; 8:45 am] 7W126, Rockville, MD 20850, (Telephone individuals associated with the grant BILLING CODE 4164–01–P Conference Call). applications, the disclosure of which VerDate Sep<11>2014 15:13 Apr 08, 2015 Jkt 235001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\09APN1.SGM 09APN1


Document Created: 2015-12-18 11:23:21
Document Modified: 2015-12-18 11:23:21
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of public workshop.
FR Citation80 FR 19087 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR